Article

CRISPR/Cas9 Awakens Silenced Genes

Study reveals untapped potential of gene-editing tool.

A method combining microhomology-mediated end-joining (MMEJ) with the gene-editing technology CRISPR/Cas9 demonstrated the ability to activate switched-off or silenced genes in a study conducted by Hokkaido University.

Genes become silenced when their promoters are methylated. In order to switch the genes back on, researchers cut out a methylated promoter using CRISPR/Cas9, and then inserted an unmethylated promoter with MMEJ, replacing the off-switch with an on switch.

To test the tool’s efficiency in cultured cells, researchers tested it on the embryonic stem cell gene NANOG and the neural cell gene OLIG2.

The results of the study showed that within 5 days, there was evidence of genes being robustly expressed. Once the OLIG2 was turned on in cultured human stem cells, the cells differentiated to neurons with high efficiency in 7 days.

The results indicate the editing tool could be used to activate other silenced promoters. The study further revealed the system did not cause any unwanted mutations in other non-targeted genes.

The study concluded the editing tool has the ability to engineer cell fates, create genetic circuits, and manipulate gene expression.

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication